ILC 2016 – Dr. Stefano Brillanti - European Medical Journal

This site is intended for healthcare professionals

Continue

ILC 2016 – Dr. Stefano Brillanti

Hepatology

Dr. Stefano Brillanti’s press conference on ‘Development of Hepatocellular Carcinoma in HCV Cirrhotic Patients Treated with Direct Acting Antivirals’ at ILC 2016.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.

We’ve noticed you’re accessing
from North/South America.